| Overall population (n = 413) | Diabetics (n = 210) | Non-diabetics (n = 203) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Asy | Atyp | Typ | Dys | Asy | Atyp | Typ | Dys | Asy | Atyp | Typ | Dys | |
Total, n (%) | 128 (31) | 152 (36.8) | 49 (11.9) | 84 (20.3) | 72 (34.3) | 75 (35.7) | 26 (12.4) | 37 (17.6) | 56 (27.6) | 77 (37.9) | 23 (11.3) | 47 (23.2) |
Follow-up, years | 203.5 | 249.3 | 85.3 | 123.9 | 109.4 | 124.5 | 41.8 | 49.6 | 93.5 | 124.7 | 43 | 75.7 |
Cardiac death, n (%) | 2 (1.5) | 0 (0) | 0 (0) | 0 (0) | 2 (2.8) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
AMI, n (%) | 0 (0) | 2 (1.3) | 2 (4) | 1 (1.2) | 0 (0) | 2 (2.7) | 1 (3.8) | 0 (0) | 0 (0) | 0 (0) | 1 (4.4) | 1 (2.1) |
UA, n (%) | 0 (0) | 2 (1.3) | 0 (0) | 1 (1.2) | 0 (0) | 2 (2.7) | 0 (0) | 1 (2.7) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Revascularization, n (%) | 6 (4.7)†# | 10 (6.6)§ | 19 (38.8)*†§ | 12 (14.3)*# | 4 (5.5)†# | 6 (8)§° | 10 (38.5)†§ | 9 (24.3)#° | 2 (3.6)†| 4 (5.2)§ | 9 (39.1)*†§ | 3 (6.4)* |
Total MACE, n (%) | 8 (6.2)†# | 14 (9.2)§ | 21 (42.8)†§ | 14 (16.7)# | 6 (8.3) | 10 (13.3) | 11 (42.3) | 10 (27) | 2 (3.6)†| 4 (5.2)§ | 10 (43.5)*†§ | 4 (8.5)* |
MACE rate per year, (%) | 3.9†| 5.6§ | 24.6†§ | 11.3 | 5.5#†| 8§ | 26.3†§ | 20.2# | 2.1†| 3.2§ | 23.2†§ | 5.3 |